Pregled bibliografske jedinice broj: 277229
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized? Reply to Tattevin and Camus
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized? Reply to Tattevin and Camus // Clinical Infectious Disease, 42 (2006), 12; 1814-1815 (međunarodna recenzija, pismo, znanstveni)
CROSBI ID: 277229 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized? Reply to Tattevin and Camus
Autori
Jakšić, Branimir ; Martinelli, Giovanni ; Perez-Oteyza, Jaime ; Hartmen, Charlotte ; Leonard, Linda ; Tack, Kenneth
Izvornik
Clinical Infectious Disease (1058-4838) 42
(2006), 12;
1814-1815
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, pismo, znanstveni
Ključne riječi
Linezolid
Sažetak
Reply to Tattevin and Camus:What can we learn from studies comparing linezolid with vancomycin in neutropenic patients when vancomycin dosages are not optimized
Izvorni jezik
Engleski
POVEZANOST RADA
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE
